Allschwil, Basel-Country, Switzerland
- Leaving a footprint in medical markets by translating medical science into medical market presence. - Skilled in review, prioritization and assembly of information, in transformation of facts into an agenda and execution of this agenda. - Experience from bio/medical R&D to BusDev and Marketing/Sales with a focus on Medical Marketing. - Broadening and improving the understanding and recognition of orphan diseases in various markets.
Supporting the medical community in the ongoing clinical trials for Trappsol® Cyclo(TM)
Analysing and evaluating external opportunities in therapeutics, instruments and diagnostics for fit with internal requirements. Participation in due diligence processes. Assembly of background information for selected therapeutic areas.
Medical Science Manager Zavesca with focus on Europe, Russia, Turkey, and MEA countries. Medical Marketing / Medical Affairs in Neurodegenerative diseases. Registered and novel indications.
Support of local (German) affiliate - coordination of Zavesca sales & marketing team. (Part time function)
Exceptional breadth of technical knowledge combined with deep understanding of commercialization process in B2B environments. Particular expertise in the Life Science Technology industry.
Covalys developed protein tagging technology which allows covalent modification of proteins in complex samples. Applications are in the field of protein labeling, protein immobilization, and protein purification. Key products developed and marketed were the SNAP-tag family, the CLIP-tag family and the ACP/MCP-tag family. These kits are offered since beginning of 2009 through New England Biolabs as part of their 'Cellular Imaging and Analysis' product line.